Pacritinib After Ruxolitinib: Five-Case Saudi Series Reports Higher Blood Counts and Smaller Spleens
A five-patient case series from Saudi Arabia reports that pacritinib, used after prior ruxolitinib exposure in advanced myelofibrosis, was associated ...
